Publication: Effectiveness and Safety of Clonazepam, Pregabalin, and Alpha Lipoic Acid for the Treatment of Burning Mouth Syndrome
dc.contributor.author | ÇİNAR, SALİH LEVENT | |
dc.contributor.author | KARTAL, DEMET | |
dc.contributor.author | Pergel, TAHA | |
dc.contributor.author | BORLU, MURAT | |
dc.contributor.institutionauthor | PERGEL, TAHA | |
dc.date.accessioned | 2020-12-17T20:59:19Z | |
dc.date.available | 2020-12-17T20:59:19Z | |
dc.date.issued | 2018-03-01T00:00:00Z | |
dc.description.abstract | Objective: Burning mouth syndrome is characterized by pain in the oral mucosa with no visible organic pathology. Few treatment options are available; however, none of them are gold-standard. Here we evaluated the effectiveness and safety of Clonazepam. pregabalin. and alpha lipoic acid for treating burning mouth syndrome. | |
dc.identifier.citation | ÇİNAR S. L. , KARTAL D., Pergel T., BORLU M., -Effectiveness and Safety of Clonazepam, Pregabalin, and Alpha Lipoic Acid for the Treatment of Burning Mouth Syndrome-, ERCIYES MEDICAL JOURNAL, cilt.40, ss.35-38, 2018 | |
dc.identifier.doi | 10.5152/etd.2018.17160 | |
dc.identifier.scopus | 85046722758 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12645/27736 | |
dc.identifier.wos | WOS:000432307500008 | |
dc.title | Effectiveness and Safety of Clonazepam, Pregabalin, and Alpha Lipoic Acid for the Treatment of Burning Mouth Syndrome | |
dc.type | Article | |
dspace.entity.type | Publication | |
local.avesis.id | e5a1e326-5d7b-4494-a75b-fb239fdfa139 | |
local.indexed.at | WOS | |
local.indexed.at | Scopus | |
local.publication.isinternational | 1 | |
relation.isAuthorOfPublication | 98473453-eb80-4aab-a087-f6081a9143b7 | |
relation.isAuthorOfPublication.latestForDiscovery | 98473453-eb80-4aab-a087-f6081a9143b7 |